U.S. Markets closed

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Simon Constable

in their efforts to help combat liver disease. The two companies said they will collaborate on clinical trials for medications for treating nonalcoholic steatohepatitis (NASH). "The intended clinical trial will be a proof of concept study," according to a press release from Gilead.